Daiwa-Securities-Group

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
1,307
Total Value
15007955
Accession Number
0001481045-25-000006
Form Type
13F-HR
Manager Name
Daiwa-Securities-Group
Data Enrichment
93% identified
1,218 identified89 unidentified

Holdings

1,307 positions • $15.0M total value
Manager:
Search and click to pin securities to the top
Page 60 of 64
464287457
Shares:19
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
ROCKET PHARMACEUTICALS, INC.
Shares:304
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
LENZ Therapeutics, Inc.
Shares:91
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
Sage Therapeutics, Inc.
Shares:239
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
Kura Oncology, Inc.
Shares:297
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
Mineralys Therapeutics, Inc.
Shares:152
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
MeiraGTx Holdings plc
Shares:330
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
Theravance Biopharma, Inc.
Shares:215
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
Day One Biopharmaceuticals, Inc.
Shares:296
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
CureVac N.V.
Shares:697
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
OMEROS CORP
Shares:191
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
Savara Inc
Shares:553
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
Cullinan Therapeutics, Inc.
Shares:218
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
Absci Corp
Shares:600
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
46434V738
Shares:29
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
Cogent Biosciences, Inc.
Shares:416
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
Xeris Biopharma Holdings, Inc.
Shares:404
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
Tyra Biosciences, Inc.
Shares:173
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
Fortrea Holdings Inc.
Shares:328
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
uniQure N.V.
Shares:158
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)